Portfolio company
Aggamin
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops an extracorporeal device to treat preeclampsia by reducing circulating pathogenic proteins for pregnant women and healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Comanche Biopharma
This biopharmaceutical company develops siRNA therapeutics targeting the causes of preeclampsia for pregnant women and healthcare providers.
NX Prenatal
This company develops exosome-based blood tests to detect pregnancy complications for physicians and expectant mothers.
LOVU
This company develops a remote patient monitoring platform that predicts and prevents pregnancy complications for expectant mothers and healthcare providers.
iPrenom
This molecular diagnostics company develops blood tests to detect and predict pregnancy complications for expectant mothers and healthcare providers.
Bloomlife
This company develops wearable medical devices and a remote monitoring platform to help healthcare providers manage high-risk pregnancies and improve maternal health outcomes.
Coagulant Therapeutics
This company develops medicines to treat acute bleeding conditions, such as postpartum haemorrhage and traumatic brain injury, for patients with urgent medical needs.
Novocuff
This company develops a cervical stabilization device to prevent preterm birth in patients with cervical shortening or premature rupture of membranes.
PATH EX, Inc.
This company develops a medical device that removes bacteria and endotoxins from the bloodstream to treat sepsis patients in clinical settings.
